NIPBL

S Wikipedije, slobodne enciklopedije
NIPBL
Identifikatori
AliasiNIPBL
Vanjski ID-jeviOMIM: 608667 MGI: 1913976 HomoloGene: 15850 GeneCards: NIPBL
Lokacija gena (čovjek)
Hromosom 5 (čovjek)
Hrom.Hromosom 5 (čovjek)[1]
Hromosom 5 (čovjek)
Genomska lokacija za NIPBL
Genomska lokacija za NIPBL
Bend5p13.2Početak36,876,769 bp[1]
Kraj37,066,413 bp[1]
Lokacija gena (miš)
Hromosom 15 (miš)
Hrom.Hromosom 15 (miš)[2]
Hromosom 15 (miš)
Genomska lokacija za NIPBL
Genomska lokacija za NIPBL
Bend15|15 A1Početak8,320,101 bp[2]
Kraj8,473,947 bp[2]
Ontologija gena
Molekularna funkcija mediator complex binding
chromo shadow domain binding
protein N-terminus binding
histone deacetylase binding
chromatin binding
protein C-terminus binding
GO:0001948, GO:0016582 vezivanje za proteine
Ćelijska komponenta SMC loading complex
nukleoplazma
Hromatin
Egzosom
jedro
integrator complex
nuclear chromosome
hromosom
Scc2-Scc4 cohesin loading complex
Biološki proces positive regulation of histone deacetylation
forelimb morphogenesis
eye morphogenesis
regulation of embryonic development
kognitivna funkcija
uterus morphogenesis
cellular response to X-ray
regulation of developmental growth
heart morphogenesis
outflow tract morphogenesis
positive regulation of ossification
GO:1901227 negative regulation of transcription by RNA polymerase II
sensory perception of sound
cellular response to DNA damage stimulus
stem cell population maintenance
ear morphogenesis
heart development
brain development
developmental growth
external genitalia morphogenesis
regulation of hair cycle
positive regulation of multicellular organism growth
embryonic digestive tract morphogenesis
gall bladder development
Regulacija ekspresije gena
embryonic cranial skeleton morphogenesis
embryonic viscerocranium morphogenesis
ćelijski ciklus
metanephros development
GO:0045996 negative regulation of transcription, DNA-templated
fat cell differentiation
maintenance of mitotic sister chromatid cohesion
embryonic forelimb morphogenesis
face morphogenesis
GO:0003257, GO:0010735, GO:1901228, GO:1900622, GO:1904488 positive regulation of transcription by RNA polymerase II
GO:0044324, GO:0003256, GO:1901213, GO:0046019, GO:0046020, GO:1900094, GO:0061216, GO:0060994, GO:1902064, GO:0003258, GO:0072212 regulation of transcription by RNA polymerase II
positive regulation of neuron migration
transcription, DNA-templated
GO:0009373 regulation of transcription, DNA-templated
multicellular organism development
mitotic sister chromatid cohesion
double-strand break repair
mitotic chromosome condensation
establishment of mitotic sister chromatid cohesion
rDNA condensation
establishment of protein localization to chromatin
cohesin loading
positive regulation of mitotic cohesin loading
Razmjena sestrinskih hromatida
Izvori:Amigo / QuickGO
Ortolozi
VrsteČovjekMiš
Entrez
Ensembl
UniProt
RefSeq (mRNK)

NM_015384
NM_133433

NM_027707
NM_201232

RefSeq (bjelančevina)

NP_056199
NP_597677

NP_081983
NP_957684

Lokacija (UCSC)Chr 5: 36.88 – 37.07 MbChr 15: 8.32 – 8.47 Mb
PubMed pretraga[3][4]
Wikipodaci
Pogledaj/uredi – čovjekPogledaj/uredi – miš

Bradavicoliki protein-B (NIPBL), znan i kao SCC2 ili delangin jest protein koji je kod ljudi kodiran genom NIPBL sa hromosoma 5.[5] NIPBL je potreban za povezivanje kohezina s DNK i glavna je podjedinica kompleksa za punjenje kohezina.[6] Heterozigotne mutacije u NIPBL čine oko 60% slučajeva sindroma Cornelije de Lange.[7]

Aminokiselinska sekvenca[uredi | uredi izvor]

Dužina polipeptidnog lanca je 2.804 aminokiseline, а molekulska težina 316.051 Da.[8].

1020304050
MNGDMPHVPITTLAGIASLTDLLNQLPLPSPLPATTTKSLLFNARIAEEV
NCLLACRDDNLVSQLVHSLNQVSTDHIELKDNLGSDDPEGDIPVLLQAVL
ARSPNVFREKSMQNRYVQSGMMMSQYKLSQNSMHSSPASSNYQQTTISHS
PSSRFVPPQTSSGNRFMPQQNSPVPSPYAPQSPAGYMPYSHPSSYTTHPQ
MQQASVSSPIVAGGLRNIHDNKVSGPLSGNSANHHADNPRHGSSEDYLHM
VHRLSSDDGDSSTMRNAASFPLRSPQPVCSPAGSEGTPKGSRPPLILQSQ
SLPCSSPRDVPPDILLDSPERKQKKQKKMKLGKDEKEQSEKAAMYDIISS
PSKDSTKLTLRLSRVRSSDMDQQEDMISGVENSNVSENDIPFNVQYPGQT
SKTPITPQDINRPLNAAQCLSQQEQTAFLPANQVPVLQQNTSVAAKQPQT
SVVQNQQQISQQGPIYDEVELDALAEIERIERESAIERERFSKEVQDKDK
PLKKRKQDSYPQEAGGATGGNRPASQETGSTGNGSRPALMVSIDLHQAGR
VDSQASITQDSDSIKKPEEIKQCNDAPVSVLQEDIVGSLKSTPENHPETP
KKKSDPELSKSEMKQSESRLAESKPNENRLVETKSSENKLETKVETQTEE
LKQNESRTTECKQNESTIVEPKQNENRLSDTKPNDNKQNNGRSETTKSRP
ETPKQKGESRPETPKQKSDGHPETPKQKGDGRPETPKQKGESRPETPKQK
NEGRPETPKHRHDNRRDSGKPSTEKKPEVSKHKQDTKSDSPRLKSERAEA
LKQRPDGRSVSESLRRDHDNKQKSDDRGESERHRGDQSRVRRPETLRSSS
RNEHGIKSDSSKTDKLERKHRHESGDSRERPSSGEQKSRPDSPRVKQGDS
NKSRSDKLGFKSPTSKDDKRTEGNKSKVDTNKAHPDNKAEFPSYLLGGRS
GALKNFVIPKIKRDKDGNVTQETKKMEMKGEPKDKVEKIGLVEDLNKGAK
PVVVLQKLSLDDVQKLIKDREDKSRSSLKPIKNKPSKSNKGSIDQSVLKE
LPPELLAEIESTMPLCERVKMNKRKRSTVNEKPKYAEISSDEDNDSDEAF
ESSRKRHKKDDDKAWEYEERDRRSSGDHRRSGHSHEGRRSSGGGRYRNRS
PSDSDMEDYSPPPSLSEVARKMKKKEKQKKRKAYEPKLTPEEMMDSSTFK
RFTASIENILDNLEDMDFTAFGDDDEIPQELLLGKHQLNELGSESAKIKA
MGIMDKLSTDKTVKVLNILEKNIQDGSKLSTLLNHNNDTEEEERLWRDLI
MERVTKSADACLTTINIMTSPNMPKAVYIEDVIERVIQYTKFHLQNTLYP
QYDPVYRLDPHGGGLLSSKAKRAKCSTHKQRVIVMLYNKVCDIVSSLSEL
LEIQLLTDTTILQVSSMGITPFFVENVSELQLCAIKLVTAVFSRYEKHRQ
LILEEIFTSLARLPTSKRSLRNFRLNSSDMDGEPMYIQMVTALVLQLIQC
VVHLPSSEKDSNAEEDSNKKIDQDVVITNSYETAMRTAQNFLSIFLKKCG
SKQGEEDYRPLFENFVQDLLSTVNKPEWPAAELLLSLLGRLLVHQFSNKS
TEMALRVASLDYLGTVAARLRKDAVTSKMDQGSIERILKQVSGGEDEIQQ
LQKALLDYLDENTETDPSLVFSRKFYIAQWFRDTTLETEKAMKSQKDEES
SEGTHHAKEIETTGQIMHRAENRKKFLRSIIKTTPSQFSTLKMNSDTVDY
DDACLIVRYLASMRPFAQSFDIYLTQILRVLGENAIAVRTKAMKCLSEVV
AVDPSILARLDMQRGVHGRLMDNSTSVREAAVELLGRFVLCRPQLAEQYY
DMLIERILDTGISVRKRVIKILRDICIEQPTFPKITEMCVKMIRRVNDEE
GIKKLVNETFQKLWFTPTPHNDKEAMTRKILNITDVVAACRDTGYDWFEQ
LLQNLLKSEEDSSYKPVKKACTQLVDNLVEHILKYEESLADSDNKGVNSG
RLVACITTLFLFSKIRPQLMVKHAMTMQPYLTTKCSTQNDFMVICNVAKI
LELVVPLMEHPSETFLATIEEDLMKLIIKYGMTVVQHCVSCLGAVVNKVT
QNFKFVWACFNRYYGAISKLKSQHQEDPNNTSLLTNKPALLRSLFTVGAL
CRHFDFDLEDFKGNSKVNIKDKVLELLMYFTKHSDEEVQTKAIIGLGFAF
IQHPSLMFEQEVKNLYNNILSDKNSSVNLKIQVLKNLQTYLQEEDTRMQQ
ADRDWKKVAKQEDLKEMGDVSSGMSSSIMQLYLKQVLEAFFHTQSSVRHF
ALNVIALTLNQGLIHPVQCVPYLIAMGTDPEPAMRNKADQQLVEIDKKYA
GFIHMKAVAGMKMSYQVQQAINTCLKDPVRGFRQDESSSALCSHLYSMIR
GNRQHRRAFLISLLNLFDDTAKTDVTMLLYIADNLACFPYQTQEEPLFIM
HHIDITLSVSGSNLLQSFKESMVKDKRKERKSSPSKENESSDSEEEVSRP
RKSRKRVDSDSDSDSEDDINSVMKCLPENSAPLIEFANVSQGILLLLMLK
QHLKNLCGFSDSKIQKYSPSESAKVYDKAINRKTGVHFHPKQTLDFLRSD
MANSKITEEVKRSIVKQYLDFKLLMEHLDPDEEEEEGEVSASTNARNKAI
TSLLGGGSPKNNTAAETEDDESDGEDRGGGTSGSLRRSKRNSDSTELAAQ
MNESVDVMDVIAICCPKYKDRPQIARVVQKTSSGFSVQWMAGSYSGSWTE
AKRRDGRKLVPWVDTIKESDIIYKKIALTSANKLTNKVVQTLRSLYAAKD
GTSS

Struktura i interakcije[uredi | uredi izvor]

Struktura SCC4 (zeleno) u kompleksu sa N-terminalnim domenom SCC2 (plavo) pupajučeg kvasca (Hinshaw et al., 2015)

NIPBL je veliki kukasti protein koji sadrži HEAT-ponavljanje.[9] Formira kompleks sa MAU2 (SCC4 u pupajućem kvascu), poznat kao kompleks kohezinskog utovara.[10] Kako ovo ime sugerira, NiPBL i MAU2 potrebni su za početno udruženje kohezina sa DNK.

Smatra se da kohezin posreduje interakcije poboljšavač-promotor i generira topološki udružujuće domene (TADS) kao i posredovanje kohezije i reguliranje arhitekture DNK. Kompleks kohezina potreban je za popravak DNK homolognom rekombinacijom. S obzirom da je NIPBL potreban za udruživanje kohezina s DNK, smatra se da je i NiPBL potreban za sve ove procese. Dosljedno, inaktivacija NiPBL-a rezultira u topološkom udruživanju gubitaka i kohezije.[11]

NIPBL se dinamički veže na hromatin, glavnim putem udruživanja sa kohezinom.[12] Kretanje NiPBL-a unutar hromatina u skladu je sa mehanizmom koji uključuje skakanje između hromosomkog koheziranja prstenova. Pokazana je i kohezina nezavisna regulacijia ekspresija odgovornog gena.[13][14]

Klinički značaj[uredi | uredi izvor]

Mutacije u ovom genu rezultiraju sindromom Cornelije de Lange (CDLS), poremećaj koji karakterizira dismorfne karakteristike lica, kašnjenje rasta, smanjenje dužine udova i mentalna invalidnost[5] kao što su ove mutacije. Obično su heterozigotni CD-ovi pogođeni smanjenjem NiPBL-a nije potpuni gubitak. Eksperimenti na ćelijama pacijenata i miševa pokazuju da je smanjenje za manje od polovine.[15] Nije poznato zašto se javlja smanjenje ekspresije NIPBL u CDL-ovima.

Reference[uredi | uredi izvor]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000164190 - Ensembl, maj 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000022141 - Ensembl, maj 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: Nipped-B homolog (Drosophila)".
  6. ^ Ciosk R, Shirayama M, Shevchenko A, Tanaka T, Toth A, Shevchenko A, Nasmyth K (2000). "Cohesin's binding to chromosomes depends on a separate complex consisting of Scc2 and Scc4 proteins". Molecular Cell. 5 (2): 243–54. doi:10.1016/S1097-2765(00)80420-7. PMID 10882066.
  7. ^ Rohatgi S, Clark D, Kline AD, Jackson LG, Pie J, Siu V, Ramos FJ, Krantz ID, Deardorff MA (juli 2010). "Facial diagnosis of mild and variant CdLS: Insights from a dysmorphologist survey". American Journal of Medical Genetics. Part A. 152A (7): 1641–53. doi:10.1002/ajmg.a.33441. PMC 4133091. PMID 20583156.
  8. ^ "UniProt, Q6KC79" (jezik: engleski). Pristupljeno 17. 10. 2021.
  9. ^ Kikuchi S, Borek DM, Otwinowski Z, Tomchick DR, Yu H (novembar 2016). "Crystal structure of the cohesin loader Scc2 and insight into cohesinopathy". Proceedings of the National Academy of Sciences of the United States of America. 113 (44): 12444–12449. doi:10.1073/pnas.1611333113. PMC 5098657. PMID 27791135.
  10. ^ Nasmyth K (oktobar 2011). "Cohesin: a catenase with separate entry and exit gates?". Nature Cell Biology. 13 (10): 1170–7. doi:10.1038/ncb2349. PMID 21968990. S2CID 25382204.
  11. ^ Ciosk R, Shirayama M, Shevchenko A, Tanaka T, Toth A, Shevchenko A, Nasmyth K (februar 2000). "Cohesin's binding to chromosomes depends on a separate complex consisting of Scc2 and Scc4 proteins". Molecular Cell. 5 (2): 243–54. doi:10.1016/s1097-2765(00)80420-7. PMID 10882066.
  12. ^ Rhodes J, Mazza D, Nasmyth K, Uphoff S (2017). "Scc2/Nipbl hops between chromosomal cohesin rings after loading". eLife. 6. doi:10.7554/eLife.30000. PMC 5621834. PMID 28914604.
  13. ^ Zuin J, Franke V, van Ijcken WF, van der Sloot A, Krantz ID, van der Reijden MI, Nakato R, Lenhard B, Wendt KS (februar 2014). "A cohesin-independent role for NIPBL at promoters provides insights in CdLS". PLOS Genetics. 10 (2): e1004153. doi:10.1371/journal.pgen.1004153. PMC 3923681. PMID 24550742.
  14. ^ van den Berg DL, Azzarelli R, Oishi K, Martynoga B, Urbán N, Dekkers DH, Demmers JA, Guillemot F (januar 2017). "Nipbl Interacts with Zfp609 and the Integrator Complex to Regulate Cortical Neuron Migration". Neuron. 93 (2): 348–361. doi:10.1016/j.neuron.2016.11.047. PMC 5263256. PMID 28041881.
  15. ^ Kawauchi S, Calof AL, Santos R, Lopez-Burks ME, Young CM, Hoang MP, Chua A, Lao T, Lechner MS, Daniel JA, Nussenzweig A, Kitzes L, Yokomori K, Hallgrimsson B, Lander AD (septembar 2009). "Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/-) mouse, a model of Cornelia de Lange Syndrome". PLOS Genetics. 5 (9): e1000650. doi:10.1371/journal.pgen.1000650. PMC 2730539. PMID 19763162.

Ovaj članak uključuje tekst iz Nacionalne medicinske biblioteke Sjedinjenih Država, koji je u javnom vlasništvu.